chronic myeloid leukemia
Conditions
Interventions
None listed
Sponsors
Kanto CML Study Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with chronic myeloid leukemia who have achieved a major cytogenetic response 2.BCR-ABL mRNA is detectable. 3.Written informed consent
Exclusion criteria
Exclusion criteria: Not determined
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Calculate and establish the conversion factor for converting BCR-ABL mRNA value to the International Scale. | — |
Countries
Japan
Contacts
Public ContactChikashi Yoshida
National Hospital Organization, Mito Medical Center Department of Hematology
Outcome results
None listed